Karen (@KarenKartaylor) profile picture

Director , Deloitte LLP, UK Centre for Health Solutions

London
Joined June 2012
Photo by Karen (@KarenKartaylor)Photo by Karen (@KarenKartaylor)
This week's blog explores the progress on delivering Universal Health Coverage and the steps needed to help deliver the UHC SDG by 2030. deloi.tt/3RjkLX8
7
This week’s blog explores how LSHC companies are designing their ESG strategies and engaging with patients to better meet their needs. deloi.tt/4a2ntc3
14
This week's blog highlights the key takeaways from FT Global Pharmaceutical and Biotechnology Conference, focusing on how pharma is responding to major global disruption and regulatory changes and the role partnerships can have on building resilience. deloi.tt/3MYwPf8
13
This week's blog raises awareness about men's health issues and introduces you to some of Deloitte’s Mo Bros and Mo Sisters who took part in this year’s campaign. deloi.tt/3RyYbeq
18
In this week's blog, we explore the rational for market consolidation of OTC medicines, and the strategic implications for companies operating within the OTC market. deloi.tt/3FSMoRv
20
This week's blog highlights the findings in our report, The Future of Health in Europe, and how Deloitte’s global vision could be used to chart Europe’s healthcare future. #DeloitteEuropeFoH deloi.tt/3smvHuD
38
This week’s blog explores the advantages and disadvantages of breast cancer screening for women and how to improve engagement and confidence in testing. deloi.tt/3Qwpdm6
18
This week’s blog explores how life science companies can adopt GenAI across all parts of their organisation to fundamentally transform end-to-end processes and gain a competitive advantage. deloi.tt/3FlYoLf
14
This week’s blog explores the implications of working in a hyper-interconnected world. blogs.deloitte.co.uk/health/…
14
This week's blog by Centre for Health Solutions explores actionable principles that consumer health companies can use to create commercial value in switching from prescription medicines to over-the-counter products. deloi.tt/46DaB9N
25
This week explores the human and economic impact of CVD in Europe and considers what can be done to reduce heart disease in a more equitable way. deloi.tt/46tL9U3
17
This week’s blog explores the findings of the US Center for Health Solutions’ latest report which calls upon pharma organisations to rethink the usual ways of doing business that often contribute to poor launch performance. deloi.tt/3PEsOxZ
14
This week’s blog explores the ingrained gender bias across the health care system and the steps to drive positive impacts on women’s health. deloi.tt/44pfn9A
23
The increasing importance of building solid foundations for data governance deloi.tt/3OHo7BX
7
This week’s blog explores how embracing circularity and achieving data integrity can drive success in meeting the NHS’s bold ambitions. blogs.deloitte.co.uk/health/…
19
This week’s blog explores what we know about the extent and costs of sports injury and how digital technology and concepts such as the ‘digital athlete’ can improve monitoring and recovery. deloi.tt/3qgCEfA
22
In this week's blog we discuss the opportunities and the challenges that organisations face in reusing their clinical data. deloi.tt/3Q9G1j5
17
This week's blog explores the current state of global track and trace regulations and the advantages that moving beyond compliance can bring. deloi.tt/3OeJ2NR
17